Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 4-Bromopyrazole | HCID 16375 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | N-Boc-3-mesyloxypiperidine | HCID 568122 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 67027251 | HCID 67027251 | 29.8% |
Reaction Steps
4-Bromopyrazole (2.94 g, 20 mmol) dissolved in DMF (20 mL) was cooled to 0° C., sodium hydride (900 mg, 22.5 mmol) was added portion-wise over 1 h. After warmed to room temperature and stirred for 1 h, tert-butyl 3-(methylsulfonyloxy)-piperidine-1-carboxylate (5.03 g, 20 mmol) was added, and the reaction mixture was heated at 100° C. overnight. The reaction mixture was quenched with saturated NH4Cl, and extracted with EtOAc. The organic layer was washed with H2O, brine, dried and concentrated. Crude mixture was column purified with mixture of EtOAc and hexane to give tert-butyl 3-(4-bromo-1H-pyrazol-1-yl)piperidine-1-carboxylate (1.97 g) as white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08999966B2 |
|---|
| Source dataset | uspto-grants-2015_04 |
|---|
| ORD ID | ord-b04695eb6dbc4c6a8499c1d35b1a15ee |
|---|
| Source note | uspto-grants-2015_04 |
|---|